CHI president Phillips Kuhl and Sequenom CMO Daniel Grosu discuss how Sequenom is applying new technology to address the next sets of clinical questions for non-invasive prenatal testing.

To learn more, please visit http://www.MolecularDXEurope.com/

CHI president Phillips Kuhl and Sequenom CMO Daniel Grosu discuss how Sequenom is applying new technology to address the next sets of clinical questions for non-invasive prenatal testing. To learn more, please visit http://www.MolecularDXEurope.com/

Molecular Diagnostics Europe 2016 | Advances in NIPT Technology at Sequenom

The CHI Podcasts are produced by the Cambridge Healthtech Institute and offer in-depth interviews with research and business leaders from many facets of biotechnology.

Share Molecular Diagnostics Europe 2016 | Advances in NIPT Technology at Sequenom

Sign up to save your podcasts

Molecular Diagnostics Europe 2016 | Advances in NIPT Technology at Sequenom

Molecular Diagnostics Europe 2016 | Advances in NIPT Technology at Sequenom